Leeds Teaching Hospitals NHS Trust, (UK) Performs Non-Invasive Histotripsy in Patient with Primary Solid Renal Tumor MINNEAPOLIS, March 30, 2023 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today the first kidney patient has been treated using the Company’s histotripsy platform. The procedure was performed […]
Category Archives: Press Release
Dallas – June 22, 2022, – ShiftKey, the largest platform for connecting independent licensed healthcare professionals with open shifts at healthcare facilities in the U.S. announced today that it has completed a strategic investment in Cleveland-based OnShift, the leading provider of workforce management technology for post-acute and long-term care facilities. “Since our founding, our goal has […]
MINNEAPOLIS, May 31, 2022 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today the fulfillment of patient enrollment required for regulatory submission of their Edison™ system to the US Food and Drug Administration (FDA). The company plans to use safety and efficacy data from combined parallel […]
The company will connect AI-driven technology with caregiver marketplaces for fast, intelligent and cost-effective shift assignments Cleveland, OH, November 10, 2021 — OnShift®, a leader in human capital management software for post-acute care and senior living, today announced the launch of a new initiative that will provide integrated access to third-party caregiver marketplaces from within OnShift’s award-winning […]
See Article: https://evtoday.com/articles/2021-oct/interventional-oncology-fast-forward-to-the-future?c4src=current:feed Histotripsy is one such therapy that has the promise of changing cancer care. It is a completely noninvasive approach akin to radiation oncology without the toxicity due to radiation and to high-intensity focused ultrasound without the problems inherent in thermal deposition in tissue with existing ablative therapies.6 The cellular destruction caused by histotripsy […]
HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy Breakthrough status for new histotripsy targeted liver therapy will help provide timely access to non-invasive liver treatment MINNEAPOLIS, Oct. 18, 2021 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today that the U.S. Food and […]
OLS Payments, an InComm Payments company, today announced a new partnership with Intelligent Clearing Network (ICN), a software-as-a-service coupon clearing company, to provide retailers with a solution addressing multiple issues related to paper coupon fraud, processing, and clearing.
Expands Blue Spark’s research capabilities into predictive machine learning and AI algorithms for predictive disease states CLEVELAND (January 19, 2020) — Blue Spark Technologies, Inc. today announced that Adam Perer has joined its TempTraq advisory board. The advisory board consists key leaders from the medical, tech and business communities and helps drive strategic initiatives within […]
Blue Spark Technologies’ TempTraq® Wearable Temperature Monitor Compatible with U.S. Military’s BATDOK™ Software Application Compatibility Enables Wireless Temperature Monitoring of Patients at the Point of Injury CLEVELAND (June 10, 2020) — Blue Spark Technologies, Inc. today announced that its TempTraq® wearable temperature monitor — a disposable, wireless patch that continuously monitors patient temperature — has […]
University Hospitals expands use of TempTraq® system wide to support frontline care workers in the fight against COVID -19 The small wearable patch notifies hospital leaders of real-time fever spikes in caregivers CLEVELAND (April 20, 2020) — To protect health care workers, patients and families, and help flatten the curve of COVID-19’s progression, University […]
- 1
- 2